Clinical Trial

Genetic and Cognitive Predictors of Aphasia Treatment Response

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Aphasia, or language impairment after a stroke, affects approximately 2 million people in the United States, with an estimated 180,000 new cases each year. The medical community cannot predict how well someone with aphasia will respond to treatment, as some people with aphasia are poor responders to intervention even when participating in empirically supported treatments. There is a strong likelihood that genetics play a role in language recovery after stroke, but very little research has been dedicated to investigating this link. This study will investigate whether two genes and cognitive abilities, such as memory, predict responsiveness to aphasia therapy for word-retrieval difficulties.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-04 -> 2026-07-01 2026-08-01
minor Completion pushed: 2026-05 -> 2026-08-31 2026-08-01
Trial Details
NCT Number NCT05179538
Lead Sponsor Ohio State University
Collaborators: Nationwide Children's Hospital
Conditions Aphasia
Enrollment 120 participants
Start Date 2020-10-23
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-31